Mellozzan

Melatonin, the active ingredient in Mellozzan, is a melatonin receptor agonist presented as an oral dosage form for oral use. It treats insomnia, jet lag and other sleep disturbances in adults.\n\nGNH India supplies Mellozzan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mellozzan, a melatonin receptor agonist, is used to address disorders of the sleep‑wake cycle.\n\nInsomnia: helps initiate and maintain sleep in individuals with difficulty falling asleep.\nJet lag: reduces the time needed to adjust to new time zones after travel.\nCircadian rhythm sleep disorder: supports alignment of the internal clock with desired sleep times.

Mellozzan may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Drowsiness during daytime\n- Headache\n- Dizziness\n- Nausea\n- Vivid dreams\n- Mild gastrointestinal discomfort\n\nSerious or Rare Side Effects:\n- Allergic reactions such as rash, itching or swelling\n- Mood changes including depression or anxiety\n- Hormonal disturbances affecting menstrual cycles\n- Severe hypotension (very low blood pressure)

Before using Mellozzan, consider the following safety measures.\n\nPregnancy: consult a healthcare professional before use.\nBreastfeeding: discuss potential risks with a physician.\nDriving: avoid operating machinery if drowsiness occurs.\nMedication review: inform the prescriber of all concurrent drugs.\nMedical conditions: use cautiously in patients with epilepsy or depression.\nStore at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Melatonin can interact with several medicines, requiring attention to avoid reduced efficacy or increased side effects.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): may increase bleeding risk.\n- Immunosuppressants (e.g., cyclosporine): potential reduction in drug effectiveness.\n\nModerate Interactions (Monitor Closely):\n- Sedatives or hypnotics: additive sleep‑inducing effect.\n- Antidepressants (e.g., SSRIs): possible alteration of melatonin metabolism.\n- Caffeine or stimulants: may counteract sleep‑promoting action.